Multi-targeted therapeutics to treat complex diseases
Single-target 'magic bullet' drugs often fail to effectively and safely treat complex diseases driven by multiple dysregulated proteins and pathways.
A computational-experimental drug discovery platform that designs multi-specific therapeutics to simultaneously target multiple disease-causing proteins.
Pharmaceutical and biotechnology companies developing treatments for complex diseases such as cancer and autoimmune disorders.
Scientist and startup founder
Working on drug discovery
I am a chemist with training in Medicinal, Organic, Computational, and Peptide chemistry. In my 25+ years in the field, I carried out drug discovery projects involving small molecules and peptides. I worked in environments of startup and global large pharma companies where I led teams and departments in all aspects of early drug discovery. I currently focus on merging experience-based knowledge of molecular optimization with ML/AI systems.




